In a study comparing patients with NF1 and optic pathway gliomas who received radiation therapy with those who did not, the relative risk of developing secondary malignancies was 3.04 (95% confidence interval (CI): 1.29-7.15) in the irradiated group [10]. Here, NF1 is linked to optic pathway glioma.